======= PAX7 ======= == Gene Information == * **Official Symbol**: PAX7 * **Official Name**: paired box 7 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5081|5081]] * **UniProt**: [[https://www.uniprot.org/uniprot/P23759|P23759]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PAX7&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PAX7|Open PubMed]] * **OMIM**: [[https://omim.org/entry/167410|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene is a member of the paired box (PAX) family of transcription factors. Members of this gene family typically contain a paired box domain, an octapeptide, and a paired-type homeodomain. These genes play critical roles during fetal development and cancer growth. The specific function of the paired box 7 gene is unknown but speculated to involve tumor suppression since fusion of this gene with a forkhead domain family member has been associated with alveolar rhabdomyosarcoma. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2008]. * **UniProt Summary**: Transcription factor playing a role in myogenesis through regulation of muscle precursor cells proliferation. {ECO:0000250|UniProtKB:P47239}. |Homeobox| |PAX| |Pax7| |skeletal muscle satellite cell commitment| |skeletal muscle satellite cell differentiation| |positive regulation of myoblast proliferation| |regulation of myoblast proliferation| |spinal cord association neuron differentiation| |dorsal/ventral neural tube patterning| |dorsal spinal cord development| |regulation of cell fate commitment| |neural tube patterning| |skeletal muscle tissue regeneration| |positive regulation of histone methylation| |skeletal muscle cell differentiation| |cell differentiation in spinal cord| |tissue regeneration| |neuron fate commitment| |regulation of histone methylation| |muscle tissue morphogenesis| |dorsal/ventral pattern formation| |muscle organ morphogenesis| |positive regulation of histone modification| |positive regulation of chromatin organization| |spinal cord development| |skeletal muscle tissue development| |regulation of DNA binding| |embryonic skeletal system development| |skeletal muscle organ development| |regulation of histone modification| |regeneration| |neural tube development| |chromatin remodeling| |cartilage development| |positive regulation of chromosome organization| |central nervous system neuron differentiation| |regulation of chromatin organization| |connective tissue development| |cell fate commitment| |striated muscle tissue development| |muscle organ development| |muscle tissue development| |regionalization| |regulation of chromosome organization| |regulation of binding| |developmental growth| |growth| |sequence-specific DNA binding| |pattern specification process| |muscle structure development| |wound healing| |skeletal system development| |tissue morphogenesis| |response to wounding| |positive regulation of organelle organization| |chordate embryonic development| |embryo development ending in birth or egg hatching| |DNA-binding transcription factor activity| |chromatin organization| |tube development| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |positive regulation of cell population proliferation| |animal organ morphogenesis| |embryo development| |central nervous system development| |negative regulation of cell death| |neuron differentiation| |chromosome organization| |epithelium development| |positive regulation of cellular component organization| |positive regulation of transcription by RNA polymerase II| |positive regulation of protein modification process| |regulation of organelle organization| |generation of neurons| |regulation of apoptotic process| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of programmed cell death| |positive regulation of cellular protein metabolic process| |regulation of cell population proliferation| |neurogenesis| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |tissue development| |regulation of cell differentiation| |regulation of protein modification process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp514|Phorbol-12-myristate-13-acetate 0.57μM R08 exp514]]|1.87| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 1/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 8059 * **Expression level (log2 read counts)**: -5.01 {{:chemogenomics:nalm6 dist.png?nolink |}}